SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (5282)12/30/2001 12:48:43 PM
From: Vector1  Read Replies (1) | Respond to of 52153
 
Peter, how bad does IMCL have to crater before you dive in. I will stipulate they have an approvable cancer drug, however, so does CRXA. These FDA problems can go on for a while.
V1



To: Biomaven who wrote (5282)12/30/2001 7:19:18 PM
From: BulbaMan  Respond to of 52153
 
...let's hope 2002 is easier for all of us...
Peter: Rather than hoping for a better 2002, here's an alternative course. Since the British Medical Journal citation you posted earlier (http://bmj.com/cgi/content/full/323/7327/1450) clearly proves the efficacy of retroactive prayer, perhaps the SI biofreak community should all pray for a better 2001. <g>
Best wishes for a healthy, prosperous and joyful New Year!


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News